Ledger.Open graph →
SEC Form D · Amendment · filed March 14, 2016

T3D Therapeutics, Inc

Offering
$3.8M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Research Triangle Park, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Barry Buzogany · Research Triangle Park, NCDirectorCharles Lineberry · Research Triangle Park, NCDirectorJohn Didsbury · Research Triangle Park, NCExec · Director · PromoterJohn A. Golden · Research Triangle Park, NCDirectorTetsuo Ochi · Hong Kong, Hong KongDirectorCharles G. Koch · Wichita, KSDirectorJames B. Hannan · Wichita, KSExec · Director · PromoterRandall A. Bushman · Wichita, KSDirectorMasakatsu J. Hayashi · Hong Kong, Hong KongDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗